Phathom Pharmaceuticals, Inc. PHAT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 84.9%-2.2pp | 87.1%-0.2pp | 87.2%+0.3pp | 86.9%+0.7pp | 86.2%+0.7pp | |
| Operating margin | -47.1%+44.2pp | -91.4%+53.7pp | -145%+90.9pp | -235.9%+114pp | -349.8%+152pp | |
| Net margin | -76.8%+49.6pp | -126.3%+60.2pp | -186.5%+103pp | -289.5%+133pp | -422.4%+183pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.4×+0.1× | 0.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.2×+0.5× | 1.7×-0.5× | 2.2×-0.2× | 2.4×-1.2× | 3.6×-0.6× | |
| Per Share | ||||||
| Book value per share | -$4.11+31.7% | -$6.01-4.4% | -$5.76-2.8% | -$5.60-19.1% | -$4.70-17.1% | |
| Valuation | ||||||
| Market capitalization | $846.21M+13.4% | $1.18B+41.3% | $835.01M+22.5% | $681.39M+56.1% | $436.62M-21.4% | |
| Price / sales | 4.1×-5.0× | 6.7×+1.1× | 5.7×-0.3× | 6×+0.6× | 5.3×-4.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phathom Pharmaceuticals, Inc.'s profit margins?
- Phathom Pharmaceuticals, Inc. (PHAT) runs a 84.9% gross margin and a -47.1% operating margin, with a -76.8% net margin.
- Where do Phathom Pharmaceuticals, Inc.'s ratios come from?
- Every ratio is computed from Phathom Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
